Kate Hasal is a full-time contract medical writer, editor and quality control consultant based out of Southern California. Her background includes a MS degree in pharmacology and toxicology, a BS degree in molecular and cellular biology, and more than 18 years’ experience in the pharmaceutical, medical communications and medical education industries.
Most recently, Kate worked for nearly 6 years as a contractor in the Medical Communications Department at Schering-Plough Research Institute, specializing in performing quality-control reviews of all types of regulatory documents, from protocols, investigator brochures and clinical study reports to full submissions and all types of pharmacovigilance documents, including annual and quarterly safety reports, periodic safety reports, risk management plans and health authority responses. Other regulatory clients have included BioSoteria, CuraGen, Fujisawa, Johnson and Johnson, and Regeneron. Previously, she supported several product publication plans, including contributing to the preparation of abstracts, posters and slide presentations; primary, secondary and review articles; and journal supplements.
From the marketing perspective, Kate has developed specialised training pieces and complete pre-launch, new indication and lifecycle extension learning systems for such clients as Pfizer, Novartis, Genentech, Berlex, Alexza Pharmaceuticals and Ortho-McNeill-Janssen, and is regularly asked to attend and provide detailed summaries of advisory board meetings and annual conferences. Working with continuing medical education (CME) clients, Kate has prepared numerous needs assessments and CME enduring and meeting materials, including slide decks, product and disease state monographs, newsletters and online interactive pieces.